{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:07Z","timestamp":1793830867731,"version":"4.6.1"},"reference-count":57,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Social determinants of health (SDHs) have been reported as relevant factors responsible for health inequity. We sought to assess clinical data from observational studies conducted in the United States evaluating the impact of SDHs on the outcomes of patients with hematologic malignancies. Thus, we performed a systematic review in 6 databases on 1 September 2021, in which paired reviewers independently screened studies and included data from 41 studies. We assessed the risk of bias using the Joanna Briggs Institute appraisal tools and analyzed the data using a descriptive synthesis. The most common SDH domains explored were health care access and quality (54.3%) and economic stability (25.6%); others investigated were education (19%) and social and community context (7.8%). We identified strong evidence of 5 variables significantly affecting survival: lack of health insurance coverage or having Medicare or Medicaid insurance, receiving cancer treatment at a nonacademic facility, low household income, low education level, and being unmarried. In contrast, the reports on the effect of distance traveled to the treatment center are contradictory. Other SDHs examined were facility volume, provider expertise, poverty, and employment rates. We identified a lack of data in the literature in terms of transportation, debt, higher education, diet, social integration, environmental factors, or stress. Our results underscore the complex nature of social, financial, and health care barriers as intercorrelated variables. Therefore, the management of hematologic malignancies needs concerted efforts to incorporate SDHs into clinical care, research, and public health policies, identifying and addressing the barriers at a patient-based level to enhance outcome equity (PROSPERO CRD42022346854)<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010690","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:04:34Z","timestamp":1693238674000},"page":"6466-6491","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":24,"title":["Disparities in survival of hematologic malignancies in the context of social determinants of health: a systematic review"],"prefix":"10.1182","volume":"7","author":[{"given":"Marisol","family":"Miranda-Galvis","sequence":"first","affiliation":[{"name":"1Georgia Cancer Center, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellen C.","family":"Tjioe","sequence":"additional","affiliation":[{"name":"1Georgia Cancer Center, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Andrew","family":"Balas","sequence":"additional","affiliation":[{"name":"2Institute of Public and Preventive Health, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Agrawal","sequence":"additional","affiliation":[{"name":"3School of Computing, University of Georgia, Athens, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-1071","authenticated-orcid":false,"given":"Jorge E.","family":"Cortes","sequence":"additional","affiliation":[{"name":"1Georgia Cancer Center, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"issue":"5","key":"2023111414505222100_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","article-title":"Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century","volume":"10","author":"Pulte","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"2023111414505222100_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/cancers14010087","article-title":"FDA-approved drugs for hematological malignancies-the last decade review","volume":"14","author":"Sochacka-\u0106wik\u0142a","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2023111414505222100_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2643-3249.BCD-20-0083","article-title":"The landscape of blood cancer research today-and where the field is headed","volume":"1","author":"Haloupek","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"41","key":"2023111414505222100_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1200\/EDBK_320079","article-title":"Understanding and addressing disparities in patients with hematologic malignancies: approaches for clinicians","volume":"41","author":"Smith-Graziani","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"29","key":"2023111414505222100_bib5","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.20.00642","article-title":"Cancer disparities and health equity: a policy statement from the American Society Of Clinical Oncology","volume":"38","author":"Patel","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"9650","key":"2023111414505222100_bib6","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(08)61690-6","article-title":"Closing the gap in a generation: health equity through action on the social determinants of health","volume":"372","author":"Marmot","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"2023111414505222100_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12875-017-0599-z","article-title":"Using self-reported data on the social determinants of health in primary care to identify cancer screening disparities: opportunities and challenges","volume":"18","author":"Lofters","year":"2017","journal-title":"BMC Fam Pract"},{"issue":"1","key":"2023111414505222100_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/ijms24010542","article-title":"Health insurance status and cancer stage at diagnosis and survival in the United States","volume":"24","author":"Zhao","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2023111414505222100_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/jamaoncol.2022.5382","article-title":"Association of residential racial and economic segregation with cancer mortality in the US","volume":"9","author":"Zhang","year":"2023","journal-title":"JAMA Oncol"},{"issue":"7","key":"2023111414505222100_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.2005.04.2846","article-title":"Social networks, social support, and survival after breast cancer diagnosis","volume":"24","author":"Kroenke","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"2023111414505222100_bib11","first-page":"790","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"2023111414505222100_bib12","author":"Team","year":"2013"},{"issue":"1","key":"2023111414505222100_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2023111414505222100_bib14","volume-title":"JBI Manual for Evidence Synthesis JBI","author":"Moola","year":"2020"},{"issue":"9","key":"2023111414505222100_bib15","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3109\/10428194.2015.1011156","article-title":"Socioeconomic status is independently associated with overall survival in patients with multiple myeloma","volume":"56","author":"Fiala","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"13","key":"2023111414505222100_bib16","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/cncr.30639","article-title":"Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study","volume":"123","author":"Perry","year":"2017","journal-title":"Cancer"},{"issue":"11","key":"2023111414505222100_bib17","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1080\/10428194.2022.2090554","article-title":"Association of insurance types and outcomes in acute promyelocytic leukemia","volume":"63","author":"Dhakal","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2023111414505222100_bib18","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1080\/10428194.2022.2102623","article-title":"Insurance-based disparities impact survival outcomes in Waldenstr\u00f6m macroglobulinemia within the United States","volume":"63","author":"Chohan","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2023111414505222100_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1634\/theoncologist.2011-0126","article-title":"Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment","volume":"16","author":"Yung","year":"2011","journal-title":"Oncologist"},{"issue":"6","key":"2023111414505222100_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clml.2014.03.003","article-title":"Outcome of acute myeloid leukemia and high-risk myelodysplastic syndrome according to health insurance status","volume":"14","author":"Al-Ameri","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"13","key":"2023111414505222100_bib21","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1080\/10428194.2019.1623884","article-title":"Insurance status impacts overall survival in Burkitt lymphoma","volume":"60","author":"Goldstein","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"2023111414505222100_bib22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2217\/fon-2018-0596","article-title":"Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphoma","volume":"15","author":"Dhakal","year":"2019","journal-title":"Future Oncol"},{"issue":"5","key":"2023111414505222100_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clml.2019.01.004","article-title":"Overall survival trends and clinical characteristics of plasmacytoma in the United States: a national cancer database analysis","volume":"19","author":"Ghiassi-Nejad","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"2023111414505222100_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjh.14631","article-title":"Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia","volume":"177","author":"Ho","year":"2017","journal-title":"Br J Haematol"},{"issue":"23","key":"2023111414505222100_bib25","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2013-07-517110","article-title":"Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era","volume":"123","author":"Tao","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2023111414505222100_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2141.2011.08982.x","article-title":"Racial patterns of extranodal natural killer\/T-cell lymphoma, nasal type, in California: a population-based study","volume":"156","author":"Ai","year":"2012","journal-title":"Br J Haematol"},{"issue":"4","key":"2023111414505222100_bib27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.29771","article-title":"Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: a SEER registry analysis","volume":"122","author":"Ailawadhi","year":"2016","journal-title":"Cancer"},{"issue":"9","key":"2023111414505222100_bib28","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.21873\/anticanres.11057","article-title":"Insurance status and other non-biological factors predict outcomes in acute myelogenous leukemia: analysis of data from the National Cancer Database","volume":"36","author":"Master","year":"2016","journal-title":"Anticancer Res"},{"issue":"7","key":"2023111414505222100_bib29","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.26474","article-title":"Hematologist\/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)\/small lymphocytic lymphoma (SLL)","volume":"118","author":"Shanafelt","year":"2012","journal-title":"Cancer"},{"issue":"32","key":"2023111414505222100_bib30","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1200\/JCO.2009.22.0038","article-title":"Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study","volume":"27","author":"Loberiza","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2023111414505222100_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1159\/000514671","article-title":"Survival disparities in multiple myeloma by health insurance status among US non-elderly adults: a SEER-based comparative analysis","volume":"144","author":"Huang","year":"2021","journal-title":"Acta Haematol"},{"issue":"19","key":"2023111414505222100_bib32","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/cncr.30139","article-title":"Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina","volume":"122","author":"Freeman","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"2023111414505222100_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.leukres.2007.07.015","article-title":"Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia","volume":"32","author":"Rodriguez","year":"2008","journal-title":"Leuk Res"},{"issue":"20","key":"2023111414505222100_bib34","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1002\/cncr.26095","article-title":"Acute myeloid leukemia: how the uninsured fare","volume":"117","author":"Bradley","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"2023111414505222100_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/10428194.2020.1832669","article-title":"Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia","volume":"62","author":"Gunaratne","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2023111414505222100_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/COC.0b013e3181dea934","article-title":"Effects of poverty and race on outcomes in acute myeloid leukemia","volume":"34","author":"Byrne","year":"2011","journal-title":"Am J Clin Oncol"},{"issue":"20","key":"2023111414505222100_bib37","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/cncr.30183","article-title":"Impact of marital status, insurance status, income, and race\/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States","volume":"122","author":"Costa","year":"2016","journal-title":"Cancer"},{"issue":"21","key":"2023111414505222100_bib38","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1002\/cncr.29436","article-title":"Nonbiological factors affecting survival in younger patients with acute myeloid leukemia","volume":"121","author":"Borate","year":"2015","journal-title":"Cancer"},{"issue":"19","key":"2023111414505222100_bib39","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1002\/cncr.29518","article-title":"Disparities in survival by insurance status in patients with Hodgkin lymphoma","volume":"121","author":"Parikh","year":"2015","journal-title":"Cancer"},{"issue":"7","key":"2023111414505222100_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clml.2021.02.001","article-title":"The impact of socioeconomic risk factors on the survival outcomes of patients with newly diagnosed multiple myeloma: a cross-analysis of a population-based registry and a tertiary care center","volume":"21","author":"Evans","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"36","key":"2023111414505222100_bib41","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1200\/JCO.2004.00.1297","article-title":"Insurance status and the use of guideline therapy in the treatment of selected cancers","volume":"23","author":"Harlan","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2023111414505222100_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jnci\/djaa048","article-title":"Health insurance coverage disruptions and cancer care and outcomes: systematic review of published research","volume":"112","author":"Yabroff","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"2023111414505222100_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12885-022-09731-w","article-title":"Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study","volume":"22","author":"Roessler","year":"2022","journal-title":"BMC Cancer"},{"issue":"8","key":"2023111414505222100_bib44","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1245\/s10434-020-09424-3","article-title":"Treatment at an academic cancer center confers better survival by stage for signet-ring cell and non-signet-ring cell gastric cancer","volume":"28","author":"Moslim","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"Supplement 1","key":"2023111414505222100_bib45","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2022-166996","article-title":"Non-relapse mortality and quality of life with shared care after allogeneic hematopoietic cell transplantation: a randomized control trial","volume":"140","author":"Abel","year":"2022","journal-title":"Blood"},{"issue":"16_suppl","key":"2023111414505222100_bib46","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1200\/JCO.2022.40.16_suppl.1510","article-title":"Impact of a shared-care model between community and academic centers for facilitating access to allogeneic and autologous stem cell transplantation","volume":"40","author":"Fein","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"2023111414505222100_bib47","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","article-title":"Marital status and survival in patients with cancer","volume":"31","author":"Aizer","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023111414505222100_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13690-020-00476-1","article-title":"The association of mental disorders with perceived social support, and the role of marital status: results from a national cross-sectional survey","volume":"78","author":"Vaingankar","year":"2020","journal-title":"Arch Publ Health"},{"issue":"12","key":"2023111414505222100_bib49","doi-asserted-by":"crossref","first-page":"e14871","DOI":"10.1097\/MD.0000000000014871","article-title":"The impact of marital status on health care utilization among Medicare beneficiaries","volume":"98","author":"Pandey","year":"2019","journal-title":"Medicine"},{"issue":"6","key":"2023111414505222100_bib50","doi-asserted-by":"crossref","first-page":"e2113533","DOI":"10.1001\/jamanetworkopen.2021.13533","article-title":"Association of cumulative social risk and social support with receipt of chemotherapy among patients with advanced colorectal cancer","volume":"4","author":"Davis","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023111414505222100_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/annonc\/mdj007","article-title":"Origins of socio-economic inequalities in cancer survival: a review","volume":"17","author":"Woods","year":"2006","journal-title":"Ann Oncol"},{"issue":"18","key":"2023111414505222100_bib52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/jnci\/djm127","article-title":"Cancer mortality in the United States by education level and race","volume":"99","author":"Albano","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"2023111414505222100_bib53","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.3390\/ijerph181910021","article-title":"Public health impacts of underemployment and unemployment in the united states: exploring perceptions, gaps and opportunities","volume":"18","author":"Pratap","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2023111414505222100_bib54","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.amepre.2017.08.024","article-title":"Health insurance status and clinical cancer screenings among U.S. adults","volume":"54","author":"Zhao","year":"2018","journal-title":"Am J Prev Med"},{"issue":"44","key":"2023111414505222100_bib55","doi-asserted-by":"crossref","first-page":"E1696","DOI":"10.1503\/cmaj.210229","article-title":"Implementing social interventions in primary care","volume":"193","author":"Bloch","year":"2021","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"19","key":"2023111414505222100_bib56","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.3390\/cancers13194786","article-title":"Model of social support for patients treated for cancer","volume":"13","author":"Pasek","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2023111414505222100_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12955-020-01392-2","article-title":"The mediating effect of social support on uncertainty in illness and quality of life of female cancer survivors: a cross-sectional study","volume":"18","author":"Lee","year":"2020","journal-title":"Health Qual Life Outcomes"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/21\/6466\/2089248\/blooda_adv-2023-010690-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/21\/6466\/2089248\/blooda_adv-2023-010690-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:52:01Z","timestamp":1699973521000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/21\/6466\/497693\/Disparities-in-survival-of-hematologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":57,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010690","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}